CD8A and COVID-19: It has also been shown that being infected during the first (ancestral virus) or second (Beta variants) wave of COVID-19 in South Africa prior to adenovirus-vector-based vaccination boosted S-specific binding antibodies, neutralizing antibodies, and ADCC, and moderately boosted CD4+ and CD8+ T-cell responses [33].